Wellgistics Health, Inc. (NASDAQ:MEDS) Stock Short Interest Climbs 147.5%

Wellgistics Health, Inc. (NASDAQ:MEDS) saw a significant growth in short interest in the month of September. As of September 15th, there was short interest totaling 430,628 shares, a growth of 147.5% from the August 31st total of 173,986 shares. Based on an average daily volume of 6,603,130 shares, the days-to-cover ratio is presently 0.1 days. Currently, 19.0% of the shares of the company are short sold.

Wall Street Analysts Forecast Growth

MEDS has been the subject of several analyst reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Wellgistics Health in a research report on Monday, September 21st. Wall Street Zen upgraded Wellgistics Health from a “strong sell” rating to a “sell” rating in a research report on Saturday, July 4th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has an average rating of “Sell”.

Wellgistics Health Trading Up 22.5%

MEDS stock traded up $0.70 during trading on Monday, hitting $3.81. The company had a trading volume of 33,265,280 shares, compared to its average volume of 2,065,332. The business has a 50 day moving average of $2.78 and a 200 day moving average of $4.12. The firm has a market capitalization of $12.18 million, a price-to-earnings ratio of -0.08 and a beta of -1.77. Wellgistics Health has a fifty-two week low of $0.82 and a fifty-two week high of $73.00.

Wellgistics Health (NASDAQ:MEDS) last released its earnings results on Monday, August 17th. The company reported ($7.13) EPS for the quarter. The business had revenue of $1.78 million for the quarter.

About Wellgistics Health

Wellgistics Health, Inc (NASDAQ:MEDS) is a healthcare technology and pharmaceutical distribution company focused on improving access to prescription medicines. The company provides infrastructure designed to connect healthcare providers, pharmacies, pharmaceutical manufacturers and patients within the prescription-drug supply chain.

Its business activities include pharmaceutical distribution and technology-enabled services intended to support medication ordering, fulfillment and delivery.